Revised SPC: Quofenix (delafloxacin meglumine) 450 mg tablets and 300 mg powder for concentrate for solution for infusion

Following PRAC recommendation, SPC updated to warn cases of aortic aneurysm and dissection, sometimes complicated by rupture (including fatal ones), and of regurgitation/incompetence of any of the heart valves have been reported in patients receiving fluoroquinolones.

Source:

electronic Medicines compendium